Piroxicam Versus Diclofenac for Post Caesarean Section Analgesia (NCT06943092) | Clinical Trial Compass
CompletedNot Applicable
Piroxicam Versus Diclofenac for Post Caesarean Section Analgesia
Nigeria108 participantsStarted 2020-01-11
Plain-language summary
Multimodal analgesic combination of pentazocine-diclofenac has been found to be superior to pentazocine-piroxicam and was associated with a higher level of maternal satisfaction. our study aims to determine the efficacy of piroxicam when compared with diclofenac as pain relief post caesarean section.
Who can participate
Age range15 Years – 45 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Pregnant women carrying live singleton fetusesat 37-42 weeks' gestational age.
* Consentingparturients who had elective caesarean section, under spinal anaesthesia.
* American Society of Anaesthesiologists (ASA) I-II physical status.
Exclusion criteria
* Caesarean sections under general or epidural anesthesia
* Known allergy to Pentazocine, Diclofenacand or Piroxicam
* Patients with uncontrolled hypertension/ pre-eclampsia or eclampsia
* Multiple gestation
* History of peptic ulcer disease,asthma
* Patients with chronic pain or on long term opioids
* Women with dead fetuses or fetuses with congenital abnormalities
* Patients who are unable to rate the pain due to psychiatric illness or illiteracy.
* Parturients with severe obstetric haemorrhage, and sickle cell haemoglobinopathy
* Those that declined consent to participate in the study despite adequate counselling.